From: [email protected] To: [email protected] Subject: Condition Petition for Thomas Rosenberger Date: Tuesday, December 31, 2019 5:15:54 PM Attachments: Question 1 Autism.pdf Question 2 Autism.pdf Question 3 Autism.pdf Question 5 Autism.pdf This message was sent from the Condition page on medicalmarijuana.ohio.gov. Box was check regarding file size being too large to upload. Action needed! Name: Thomas Rosenberger Address: 815 Grandview Ave Suite 400, Columbus, OH, 43215 Phone: (614) 706-3782 Email: [email protected] Specific Disease or Condition: Autism Spectrum Disorder (ASD) Information from experts who specialize in the disease or condition. See attached file Question 1 Autism.pdf Relevant medical or scientific evidence pertaining to the disease or condition. See attached file Question 2 Autism.pdf Consideration of whether conventional medical therapies are insufficient to treat or alleviate the disease or condition. See attached file Question 3 Autism.pdf Evidence supporting the use of medical marijuana to treat or alleviate the disease or condition, including journal articles, peer-reviewed studies, and other types of medical or scientific documentation. File larger than 3MB Letters of support provided by physicians with knowledge of the disease or condition. This may include a letter provided by the physician treating the petitioner, if applicable. See attached file Question 5 Autism.pdf Question 1 Information from experts who specialize in the disease or condition Contents Overview – 3 Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014 – 4 Overview Autism spectrum disorder (ASD) is characterized by challenges with social skills, repetitive behaviors, speech and nonverbal communication. The conditions impact varies wildly, with some patients functioning at a high level with little intervention, while other patients are never able to live independently. We still know little about the cause of ASD, but evidence suggests the condition is on the rise. The Autism and Developmental Disabilities Monitoring Network compiles reports like the one attached below regularly regarding the rate of ASD. In 2014, they estimated 16.8 per 1,000 children aged 8 have ASD. With the rate of ASD on the rise it is more important than ever that we provide physicians the tools they need to treat this condition based on their assessment of an individual patient. The evidence provided within this application shows clearly that medical marijuana can be an effective treatment for some individuals with ASD. Morbidity and Mortality Weekly Report Surveillance Summaries / Vol. 67 / No. 6 April 27, 2018 Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Surveillance Summaries CONTENTS Introduction ............................................................................................................2 Methods ....................................................................................................................4 Results .......................................................................................................................9 Discussion ............................................................................................................. 12 Limitations ............................................................................................................ 15 Future Surveillance Directions....................................................................... 15 Conclusion ............................................................................................................ 15 References ............................................................................................................. 16 The MMWR series of publications is published by the Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, Atlanta, GA 30329-4027. Suggested citation: [Author names; first three, then et al., if more than six.] [Title]. MMWR Surveill Summ 2018;67(No. SS-#):[inclusive page numbers]. Centers for Disease Control and Prevention Robert R. Redfield, MD, Director Anne Schuchat, MD, Principal Deputy Director Leslie Dauphin, PhD, Acting Associate Director for Science Joanne Cono, MD, ScM, Director, Office of Science Quality Chesley L. Richards, MD, MPH, Deputy Director for Public Health Scientific Services Michael F. Iademarco, MD, MPH, Director, Center for Surveillance, Epidemiology, and Laboratory Services MMWR Editorial and Production Staff (Serials) Charlotte K. Kent, PhD, MPH, Acting Editor in Chief, Executive Editor Martha F. Boyd, Lead Visual Information Specialist Christine G. Casey, MD, Editor Maureen A. Leahy, Julia C. Martinroe, Mary Dott, MD, MPH, Online Editor Stephen R. Spriggs, Tong Yang, Teresa F. Rutledge, Managing Editor Visual Information Specialists David C. Johnson, Lead Technical Writer-Editor Quang M. Doan, MBA, Phyllis H. King, Jeffrey D. Sokolow, MA, Project Editor Paul D. Maitland, Terraye M. Starr, Moua Yang, Information Technology Specialists MMWR Editorial Board Timothy F. Jones, MD, Chairman William E. Halperin, MD, DrPH, MPH Jeff Niederdeppe, PhD Matthew L. Boulton, MD, MPH King K. Holmes, MD, PhD Patricia Quinlisk, MD, MPH Virginia A. Caine, MD Robin Ikeda, MD, MPH Patrick L. Remington, MD, MPH Katherine Lyon Daniel, PhD Rima F. Khabbaz, MD Carlos Roig, MS, MA Jonathan E. Fielding, MD, MPH, MBA Phyllis Meadows, PhD, MSN, RN William L. Roper, MD, MPH David W. Fleming, MD Jewel Mullen, MD, MPH, MPA William Schaffner, MD Surveillance Summaries Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014 Jon Baio, EdS1; Lisa Wiggins, PhD1; Deborah L. Christensen, PhD1; Matthew J Maenner, PhD1, Julie Daniels, PhD2; Zachary Warren, PhD3; Margaret Kurzius-Spencer, PhD4; Walter Zahorodny, PhD5; Cordelia Robinson Rosenberg, PhD6; Tiffany White, PhD7; Maureen S. Durkin, PhD8; Pamela Imm, MS8; Loizos Nikolaou, MPH1,9; Marshalyn Yeargin-Allsopp, MD1; Li-Ching Lee, PhD10; Rebecca Harrington, PhD10; Maya Lopez, MD11; Robert T. Fitzgerald, PhD12; Amy Hewitt, PhD13; Sydney Pettygrove, PhD4; John N. Constantino, MD12; Alison Vehorn, MS3; Josephine Shenouda, MS5; Jennifer Hall-Lande, PhD13; Kim Van Naarden Braun, PhD1; Nicole F. Dowling, PhD1 1National Center on Birth Defects and Developmental Disabilities, CDC; 2University of North Carolina, Chapel Hill; 3Vanderbilt University Medical Center, Nashville, Tennessee; 4University of Arizona, Tucson; 5Rutgers University, Newark, New Jersey; 6University of Colorado School of Medicine at the Anschutz Medical Campus; 7Colorado Department of Public Health and Environment, Denver; 8University of Wisconsin, Madison; 9Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee; 10Johns Hopkins University, Baltimore, Maryland; 11University of Arkansas for Medical Sciences, Little Rock; 12Washington University in St. Louis, Missouri; 13University of Minnesota, Minneapolis Abstract Problem/Condition: Autism spectrum disorder (ASD). Period Covered: 2014. Description of System: The Autism and Developmental Disabilities Monitoring (ADDM) Network is an active surveillance system that provides estimates of the prevalence of autism spectrum disorder (ASD) among children aged 8 years whose parents or guardians reside within 11 ADDM sites in the United States (Arizona, Arkansas, Colorado, Georgia, Maryland, Minnesota, Missouri, New Jersey, North Carolina, Tennessee, and Wisconsin). ADDM surveillance is conducted in two phases. The first phase involves review and abstraction of comprehensive evaluations that were completed by professional service providers in the community. Staff completing record review and abstraction receive extensive training and supervision and are evaluated according to strict reliability standards to certify effective initial training, identify ongoing training needs, and ensure adherence to the prescribed methodology. Record review and abstraction occurs in a variety of data sources ranging from general pediatric health clinics to specialized programs serving children with developmental disabilities. In addition, most of the ADDM sites also review records for children who have received special education services in public schools. In the second phase of the study, all abstracted information is reviewed systematically by experienced clinicians to determine ASD case status. A child is considered to meet the surveillance case definition for ASD if he or she displays behaviors, as described on one or more comprehensive evaluations completed by community-based professional providers, consistent with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) diagnostic criteria for autistic disorder; pervasive developmental disorder–not otherwise specified (PDD-NOS, including atypical autism); or Asperger disorder. This report provides updated ASD prevalence estimates for children aged 8 years during the 2014 surveillance year, on the basis of DSM-IV-TR criteria, and describes characteristics of the population of children with ASD. In 2013, the American Psychiatric Association published the